Literature DB >> 7678205

Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.

D J Langer1, A Kuo, K Kariko, M Ahuja, B D Klugherz, K M Ivanics, J A Hoxie, W V Williams, B T Liang, D B Cines.   

Abstract

Binding of urokinase-type plasminogen activator (u-PA) to specific receptors (u-PAR) on the surface of endothelial cells contributes to the regulation of plasmin-dependent processes such as fibrinolysis and angiogenesis. We studied the effect of raising intracellular levels of cyclic AMP (cAMP) and/or activating protein kinase C on the expression of u-PAR in cultured human umbilical vein endothelial cells (HUVEC). Incubation of HUVEC with forskolin stimulated a time- and concentration-dependent increase in the expression of u-PAR, measured both by an increase in the specific binding of radiolabeled single-chain u-PA (scu-PA) and by increased binding of anti-u-PAR antibodies. Maximal increase in u-PAR expression (81 +/- 11% above control, n = 11) was not associated with a change in receptor affinity for scu-PA when HUVEC were incubated for 20 hours at 37 degrees C with 50 microM forskolin. Receptor induction by forskolin was inhibited when HUVEC were preincubated with deoxyadenosine monophosphate (DAM), an inhibitor of adenylyl cyclase. A similar increase in receptor expression (128 +/- 27% above control, n = 3) was induced by the cAMP analogue 8-bromoadenosine 3':5'-cyclic monophosphate (50 mM). Forskolin induced an approximately twofold increase in the expression of a single approximately 1.4-kb u-PAR messenger RNA (mRNA) transcript within 2 hours. Phorbol myristate acetate (PMA) also stimulated a time- and concentration-dependent increase in specific scu-PA binding. The maximal increase in u-PAR expression (254 +/- 27% above control, n = 11) was observed when HUVEC were preincubated with 10 nM PMA for 20 hours. Induction of u-PAR by PMA was inhibited when HUVEC were preincubated with either cycloheximide or H7 but was unaffected by DAM. u-PAR induced by PMA showed a reduced affinity for scu-PA (Kd, 14 +/- 2 nM versus 3.6 +/- 0.6 nM, p < 0.001; n = 8). PMA stimulation for 20 hours resulted in a sixfold increase in a single approximately 1.4-kb u-PAR mRNA transcript, with increased levels detectable within 30 minutes. Coincubation of HUVEC with optimal concentrations of forskolin and PMA for 20 hours produced a fully additive increase in u-PAR expression at both the mRNA and protein levels. These data suggest that both cAMP-dependent and protein kinase C-dependent protein kinase pathways may independently regulate u-PAR expression in human endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678205     DOI: 10.1161/01.res.72.2.330

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  7 in total

1.  Differential expression of the urokinase receptor (CD87) in arthritic and normal synovial tissues.

Authors:  Z Szekanecz; G K Haines; A E Koch
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

2.  Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes.

Authors:  E Bianchi; E Ferrero; F Fazioli; F Mangili; J Wang; J R Bender; F Blasi; R Pardi
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

3.  Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy.

Authors:  C M Bloor; L Nimmo; M D McKirnan; Y Zhang; F C White
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

4.  Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.

Authors:  A J Wilson; P R Gibson
Journal:  Gut       Date:  2000-07       Impact factor: 23.059

5.  Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney.

Authors:  S N Wagner; M J Atkinson; C Wagner; H Höfler; M Schmitt; O Wilhelm
Journal:  Histochem Cell Biol       Date:  1996-01       Impact factor: 4.304

6.  Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma.

Authors:  S N Wagner; M J Atkinson; S Thanner; C Wagner; M Schmitt; O Wilhelm; M Rotter; H Höfler
Journal:  Am J Pathol       Date:  1995-07       Impact factor: 4.307

7.  Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity.

Authors:  P Koolwijk; M G van Erck; W J de Vree; M A Vermeer; H A Weich; R Hanemaaijer; V W van Hinsbergh
Journal:  J Cell Biol       Date:  1996-03       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.